First Tracks Biotherapeutics, Inc. (TRAX)
NASDAQ: TRAX · Real-Time Price · USD
18.16
-0.84 (-4.42%)
At close: Apr 24, 2026, 4:00 PM EDT
18.20
+0.04 (0.22%)
After-hours: Apr 24, 2026, 7:57 PM EDT
TRAX Stock Forecast
Stock Price Forecast
The 4 analysts that cover TRAX stock have a consensus rating of "Strong Buy" and an average price target of $40.5, which forecasts a 123.02% increase in the stock price over the next year. The lowest target is $31 and the highest is $46.
Price Target: $40.5 (+123.02%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TRAX stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 |
|---|---|
| Strong Buy | 1 |
| Buy | 3 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Initiates $46 | Buy | Initiates | $46 | +153.30% | Apr 24, 2026 |
| JP Morgan | JP Morgan | Buy Initiates $31 | Buy | Initiates | $31 | +70.70% | Apr 23, 2026 |
| Barclays | Barclays | Buy Initiates $40 | Buy | Initiates | $40 | +120.26% | Apr 22, 2026 |
| UBS | UBS | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +147.80% | Apr 21, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.